ondansetron and ski 2053r

ondansetron has been researched along with ski 2053r in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, JH; Bahng, H; Chang, HM; Kang, WC; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, JS	1

Trials

1 trial(s) available for ondansetron and ski 2053r

Article	Year
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2 Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Creatinine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrectomy; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Leukopenia; Male; Malonates; Metabolic Clearance Rate; Metoclopramide; Middle Aged; Ondansetron; Organoplatinum Compounds; Proteinuria; Stomach Neoplasms; Survival Analysis; Vomiting	2002

Article

Year

Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.

Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2

Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Creatinine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrectomy; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Leukopenia; Male; Malonates; Metabolic Clearance Rate; Metoclopramide; Middle Aged; Ondansetron; Organoplatinum Compounds; Proteinuria; Stomach Neoplasms; Survival Analysis; Vomiting

2002